DKSH, the leading Market Expansion Services provider with a focus on Asia, has signed an agreement with Clinova, a UK-based consumer healthcare company, to drive its expansion in four Asian markets.
Media release
Bangkok, Thailand, March 8, 2017 â DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, will provide marketing, sales, distribution and logistics as well as regulatory services for Clinova's range of O.R.S. Hydration Tablets across Asia. Consumers in Hong Kong, Malaysia, Singapore and Thailand will have access to the products in pharmacies and hospitals as well as through e-commerce channels.
O.R.S. Hydration Tablets are made from a scientifically balanced formula of electrolytes, glucose and minerals. The soluble tablet prevents dehydration and is particularly suitable for people with an active lifestyle, such as professional and recreational athletes.
âWith a hot climate and a growing middle class placing high value on personal health, Asia is an increasingly attractive region for Clinova. Building our own Asian growth platform would be costly and time consuming, hence we rely on DKSH to quickly grow into new markets. DKSH's ability to offer regulatory, commercial and distribution services across multiple channels and markets is invaluable to us,â says Charles Toomey, Chairman APAC, Clinova.
âCompanies like Clinova that are looking for growth are faced with a decision: will I invest my resources into building a platform or do I buy them? Outsourcing to DKSH provides a fast, low-risk and effective way to grow. With more than 4,200 sales and marketing experts and a broad direct distribution network across health, consumer and e-commerce channels, DKSH's growth platform is unmatched across Asia,â says Andrew Frye, Head Business Unit Healthcare, DKSH.
This agreement will further strengthen DKSH's market position in the region while contributing gradually to the Group's overall profitability over time.
For further information please contact:
| |
DKSH Healthcare |
Kalle Siebring Manager, Group Communications Business Unit Consumer Goods and Healthcare Phone +66 2 220 9739 kalle.siebring@dksh.com |
About Clinova
Clinova is a UK based consumer healthcare company focused on developing, manufacturing and marketing healthcare products and medical devices. The company has a specific strategy of penetrating the fast-growing Middle East, Africa, South American and Asia Pacific markets. Clinova specializes in the introduction of pharmaceutical products and consumer health products by our world class research projects. Additionally, Clinova is committed to product-focused collaborations with academic, biotech and pharmaceutical partners allowing the potential for significant return in the form of downstream royalties and profit-sharing. Clinovaâs strategy provides a balanced model that maximizes the commercial opportunity for drug discovery and augments our capability to deliver sustained value and commercial success.
About DKSH
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets. Publicly listed on the SIX Swiss Exchange since 2012, DKSH is a global company headquartered in Zurich. With 780 business locations in 36 countries â 750 of them in Asia â and 30,320 specialized staff, DKSH generated net sales of CHF 10.5 billion in 2016. DKSH was founded in 1865. With strong Swiss heritage, the company has a long tradition of doing business in and with Asia and is deeply rooted in communities and businesses across Asia Pacific.
DKSH Business Unit Healthcare is the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia. Custom-made offerings comprise registration, regulatory services, market entry studies, importation, customs clearance, marketing and sales, capillary physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With 120 business locations in 13 countries and around 9,740 specialized staff, Business Unit Healthcare serves over 150,000 customers and generated net sales of CHF 5.5 billion in 2016.